PREDICTING ALL-CAUSE AND PROSTATE CANCER SPECIFIC MORTALITY FOLLOWING DEFINITIVE THERAPY FOR LOCALIZED PROSTATE CANCER

被引：0
|
作者：
Isariyawongse, Brandon
Stephenson, Andrew
Kattan, Michael
Gao, Tianming
Haslag-Minoff, Jennifer
Nepple, Kenneth
Piccirillo, Jay
Ciezki, Jay
Klein, Eric
Kibel, Adam
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.212
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
161
引用
收藏
页码：E67 / E67
页数：1
相关论文
共 50 条
  • [1] Energetic risk and prostate cancer-specific and all-cause mortality in two large cohorts of men with localized prostate cancer
    Ma, Jing
    Giovannucci, Edward
    Nguyen, Paul L.
    Qiu, Weiliang
    Chavarro, Jorge
    Rosner, Bernard
    Cook, Nancy R.
    Platz, Elizabeth A.
    Gaziano, J. Michael
    Pollak, Michael
    Stampfer, Meir J.
    CANCER RESEARCH, 2012, 72
  • [2] Prior cancer diagnosis in men with nonmetastatic prostate cancer and the risk of prostate cancer specific and all-cause mortality
    Mirabeau-Beale, Kristina
    Chen, Ming-Hui
    D'Amico, Anthony Victor
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [3] OVERALL AND CANCER SPECIFIC SURVIVAL FOLLOWING DEFINITIVE THERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER IN THE PROSTATE-SPECIFIC ANTIGEN ERA
    Stephenson, Andrew
    Klein, Eric
    Ciezki, Jay
    Reddy, Chandana
    Kattan, Michael
    Yu, Changhong
    Deasy, Joseph
    Michalski, Jeff
    Kallogjeri, Donna
    Lubahn, Jessica
    Luly, Jason
    Piccirillo, Jay
    Kibel, Adam
    JOURNAL OF UROLOGY, 2010, 183 (04): : E113 - E113
  • [4] Long-term prostate cancer mortality, all-cause survival and morbidity following prostate brachytherapy
    Skouteris, V
    Stone, N.
    Sheu, R-D
    Stock, R.
    EUROPEAN UROLOGY, 2022, 81 : S1396 - S1397
  • [5] NOMOGRAMS PREDICTING 15-YEAR PROSTATE CANCER SPECIFIC MORTALITY AND PROSTATE CANCER RECURRENCE FOLLOWING DEFINITIVE BRACHYTHERAPY WITH OR WITHOUT EXTERNAL BEAM RADIATION FOR THE TREATMENT OF LOCALIZED PROSTATE CANCER.
    Ali, Adnan
    Stone, Nelson
    Stock, Richard
    Tewari, Ashutosh
    JOURNAL OF UROLOGY, 2015, 193 (04): : E785 - E785
  • [6] RISK OF ALL-CAUSE AND PROSTATE CANCER-SPECIFIC MORTALITY AFTER BRACHYTHERAPY IN MEN WITH SMALL PROSTATE SIZE
    Nguyen, Paul L.
    Chen, Ming H.
    Choueiri, Toni K.
    Hoffman, Karen E.
    Hu, Jim C.
    Martin, Neil E.
    Beard, Claw J.
    Dosoretz, Daniel E.
    Moran, Brian J.
    Katin, Michael J.
    Braccioforte, Michelle H.
    Ross, Rud
    Salenius, Sharon A.
    Kantoff, Philip W.
    D'Amico, Anthony V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1318 - 1322
  • [7] Diabetes and Risk of All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors
    Chen, Xiong
    Xiao, Jian
    Wang, Yafeng
    Shen, Feixia
    DIABETES, 2020, 69
  • [8] Prostate-specific antigen nadir and testosterone level at prostate-specific antigen failure following radiation and androgen suppression therapy for unfavorable-risk prostate cancer and the risk of all-cause and prostate cancer-specific mortality
    Bitterman, Danielle S.
    Chen, Ming-Hui
    Wu, Jing
    Renshaw, Andrew A.
    Loffredo, Marian
    Kantoff, Philip W.
    Small, Eric J.
    D'Amico, Anthony V.
    CANCER, 2021, 127 (15) : 2623 - 2630
  • [9] PSA control following definitive therapy for clinically localized prostate cancer
    D'Amico, A
    MOLECULAR UROLOGY, 1999, 3 (03) : 207 - 211
  • [10] TIMING OF SALVAGE ANDROGEN DEPRIVATION THERAPY FOLLOWING PROSTATE RADIOTHERAPY DOES NOT ADVERSELY AFFECT ALL-CAUSE OR PROSTATE CANCER SPECIFIC SURVIVAL
    Sagalovich, Daniel
    Leapman, Michael
    Sfakianos, John
    Hall, Simon
    Stock, Richard
    Stone, Nelson
    JOURNAL OF UROLOGY, 2015, 193 (04): : E1085 - E1085
12345